Geriatrics
FDA/CDC
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
Opinion
Updates in aspirin use, aducanumab, and CKD diagnostic criteria in geriatric medicine
Internist gives context and background information regarding new Alzheimer’s therapy.
News
Opioid use in the elderly a dementia risk factor?
Exposure to these drugs may be another modifiable risk factor for dementia.
News
Hearing, vision loss combo a colossal risk for cognitive decline
Those with dual sensory impairment had an eightfold higher risk for cognitive impairment.
From the Journals
Study casts doubt on safety, efficacy of L-serine supplementation for AD
When given to patients with AD, L-serine supplements could be driving abnormally increased serine levels in the brain even higher.
From the Journals
Higher industriousness reduces risk of predementia syndrome in older adults
Certain facets of conscientiousness could be treatment targets to reduce motoric cognitive risk syndrome and dementia.
FDA/CDC
FDA clears diagnostic test for early Alzheimer’s
“There is a new option that can typically be completed the same day and can give doctors the same information regarding brain amyloid status,...
From the Journals
Seven hours of sleep is ideal for middle aged and older
Too much or too little sleep may contribute to poor mental health and cognitive performance.
Savvy Psychopharmacology
Deprescribing in older adults: An overview
Mr. J, age 73, has a 25-year history of generalized anxiety disorder and major depressive disorder.
Latest News
New blood biomarker to detect early dementia?
The study team is looking to source a larger sample size of AD blood samples to replicate the findings.
Conference Coverage
Virtual reality an ‘exciting opportunity’ for geriatric psychiatry
There is evidence that VR technology is feasible for older adults, with specific applications in cognitive disorders, said Dr. Harmehr Sekhon.